Statistics for Eli Lilly & (id:8473 LLY)
Valuation metrics
Market cap
692.82B
Enterprise value
709.06B
Trailing P/E (ttm)
82.66
Forward P/E
34.00
PEG ratio
34.00
Price/Sales (ttm)
16.95
Price/Book (mrq)
48.68
Enterprise Value/Revenue
17.35
Enterprise Value/EBITDA
42.80
Overview
Shares outstanding
899.32M
Float
897.26M
Shares short
5.84M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
3.03M
Average volume (90 days)
Price summary
52-Week low
567.64
52-Week high
972.53
52-Week change
25.67%
Beta
3.00
50-Day moving average
824.59
200-Day moving average
838.51
Dividends and splits
Forward annual dividend rate
5.20
Forward annual dividend yield
5.00
Trailing annual dividend rate
5.03%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
1.24
Payout ratio
3.00
Dividend date
March 10, 2025
Ex-dividend date
February 14, 2025
Last split factor
2:1
Last split date
October 16, 1997
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
20.48%
Operating margin
39.77%
Operational effectiveness
Return on assets
13.95%
Return on equity
65.32%
Income statement
Revenue (ttm)
45.37
Revenue per share (ttm)
45.37
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
27.04B
EBITDA
16.72B
Net income to common (ttm)
8.37B
Diluted EPS (ttm)
9.32
Quarterly earnings growth (yoy)
20.43%
Balance sheet
Total cash (mrq)
3.52B
Total cash per share (mrq)
3.91
Total debt (mrq)
31.23B
Total Debt/Equity (mrq)
218.08
Current ratio (mrq)
127.30%
Book value per share (mrq)
15.82
Cash flow
Cash flow statement
6.03B
Levered free cash flow (LFCF)
-1,306,887,552.00